Legal & General Group’s Rubius Therapeutics, Inc RUBY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-14,367
| Closed | -$79K | – | 3736 |
|
|
2022
Q1 | $79K | Hold |
14,367
| – | – | ﹤0.01% | 2923 |
|
|
2021
Q4 | $140K | Buy |
14,367
+107
| +0.8% | +$1.04K | ﹤0.01% | 2834 |
|
|
2021
Q3 | $255K | Buy |
14,260
+7,884
| +124% | +$141K | ﹤0.01% | 2608 |
|
|
2021
Q2 | $155K | Buy |
6,376
+1,629
| +34% | +$39.6K | ﹤0.01% | 2603 |
|
|
2021
Q1 | $126K | Sell |
4,747
-275
| -5% | -$7.3K | ﹤0.01% | 2557 |
|
|
2020
Q4 | $38K | Hold |
5,022
| – | – | ﹤0.01% | 2881 |
|
|
2020
Q3 | $25K | Sell |
5,022
-1,436
| -22% | -$7.15K | ﹤0.01% | 2918 |
|
|
2020
Q2 | $39K | Sell |
6,458
-1,063
| -14% | -$6.42K | ﹤0.01% | 2801 |
|
|
2020
Q1 | $33K | Sell |
7,521
-1,018
| -12% | -$4.47K | ﹤0.01% | 2736 |
|
|
2019
Q4 | $81K | Buy |
8,539
+1,317
| +18% | +$12.5K | ﹤0.01% | 2663 |
|
|
2019
Q3 | $57K | Hold |
7,222
| – | – | ﹤0.01% | 2695 |
|
|
2019
Q2 | $113K | Buy |
7,222
+1,607
| +29% | +$25.1K | ﹤0.01% | 2490 |
|
|
2019
Q1 | $102K | Buy |
5,615
+3,770
| +204% | +$68.5K | ﹤0.01% | 2478 |
|
|
2018
Q4 | $30K | Hold |
1,845
| – | – | ﹤0.01% | 2912 |
|
|
2018
Q3 | $44K | Buy |
+1,845
| New | +$44K | ﹤0.01% | 2846 |
|